BIOSIMILARITY

Clinical trials for BIOSIMILARITY explained in plain language.

Never miss a new study

Get alerted when new BIOSIMILARITY trials appear

Sign up with your email to follow new studies for BIOSIMILARITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

First test of a potential cheaper copy of a blockbuster drug

Knowledge-focused Not yet recruiting

This study aims to see if a new, potentially lower-cost version of the drug dupilumab (Dupixent®) is similar to the original. It will involve 198 healthy Chinese adult men who will receive a single injection and be closely monitored for safety and how the drug moves through their…

Matched conditions: BIOSIMILARITY

Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:32 UTC

BIOSIMILARITY

Get alerted when new BIOSIMILARITY trials appear

First test of a potential cheaper copy of a blockbuster drug